Thursday, September 20, 2012 7:34:19 AM
DYAX. Dyax Corp. and Kadmon Sign Strategic Licensing Agreement for DX-2400
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html
Novel MMP-14 Inhibitor to be Developed in Multi-Indication Oncology Program
http://finance.yahoo.com/news/dyax-corp-kadmon-sign-strategic-113000340.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
